| Mission type | Biological research |
|---|---|
| Operator | Santa Clara University |
| COSPAR ID | 1998-067NG |
| SATCAT no. | 43019 |
| Website | EcAMSat |
| Mission duration | 25 days[1] 152.5 hr Main Experiment[2] |
| Spacecraft properties | |
| Bus | NASA NanoSat 1.0 Bus |
| Manufacturer | NASA |
| Launch mass | 10.7 kilograms (24 lb) |
| Start of mission | |
| Launch date | 12 November 2017, 12:19 UTC[3][4] |
| Rocket | Antares 230 |
| Launch site | MARS LP-0A |
| Contractor | Orbital ATK |
| End of mission | |
| Decay date | 8 December 2021[5] |
| Orbital parameters | |
| Reference system | Geocentric |
| Regime | Low Earth |
| Perigee altitude | 405.7 kilometres (252.1 mi) |
| Apogee altitude | 413.4 kilometres (256.9 mi) |
| Inclination | 51.6 degrees |
| Period | 92.6 minutes |
| Epoch | 1 December 2017[6] |
EcAMSat, or E. coli AntiMicrobial Satellite, was NASA's first 6U CubeSat, developed to investigate the effects of microgravity on the antibiotic resistance of E. coli. The spacecraft was launched aboard an Orbital ATK Antares rocket from Wallops Flight Facility on 12 November 2017, and was deployed from the International Space Station on 20 November 2017.
- ^ Cite error: The named reference
dashboardwas invoked but never defined (see the help page). - ^ Spremo, Stephen (19 June 2014). E. coli AntiMicrobial Satellite (EcAMSat): Science Payload System Development and Test (PDF). SSC14. Retrieved 28 November 2017.
- ^ Clark, Stephen (12 November 2017). "Space station cargo shipment blasts off aboard Antares rocket". Spaceflight Now. Retrieved 28 November 2017.
- ^ Foust, Jeff (12 November 2017). "Antares launches Cygnus spacecraft to ISS". SpaceNews. Retrieved 28 November 2017.
- ^ "ECAMSAT". N2YO.com. 8 December 2021. Retrieved 14 December 2021.
- ^ "Satellite Catalog". N2YO.com. Archived from the original on 1 December 2017. Retrieved 1 December 2017.